Alpa Laboratories DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.74×	0.90×	0.76×	0.81×	0.79×
	−1.76×	13.93×	10.06×	3.36×	2.56×
	−3.0%	1.1%	2.3%	5.7%	6.7%
	0.46×	0.46×	0.56×	0.62×	0.57×
	1.30×	1.30×	1.30×	1.20×	1.24×
	2.4%	8.5%	12.6%	11.5%	9.7%
	8.4%	8.4%	12.1%	11.7%	9.9%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ALPA₹49.28

Alpa Laboratories Limited

· Pharma & Health

₹ CrorePeersBALPHARMA KREBSBIO NATCAPSUQ VINEETLAB NECLIFE AAREYDRUGS BIOFILCHEM MANGALAMMcap ₹104 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.79	0.81	0.76	0.90	0.74
Interest Burden (Pretax/EBIT) ×	2.56	3.36	10.06	13.93	-1.76
EBIT Margin %	6.74	5.66	2.27	1.13	-3.03
Asset Turnover ×	0.57	0.62	0.56	0.46	0.46
Financial Leverage (Assets/Equity) ×	1.24	1.20	1.30	1.30	1.30
ROE (5-step product, year-end total equity) %	9.69	11.50	12.61	8.48	2.37
ROE (owners' profit / average owners' equity) %	9.86	11.71	12.06	8.39	8.39

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.